Pursuant to Regulation 29 of the Listing Regulations, Ajanta Pharma has informed about a Meeting of the Board of Directors of the Company will be held on Wednesday, 3rd May, 2017 at the Registered Office of the Company at Ajanta House, Charkop, Kandivli (West), Mumbai - 400 067, to Consider and approve the audited Financial Results of the Company for the quarter and year ended 31st March, 2017 and Consider and approve Financial Statements for the year ended 31st March, 2017.
The above information is a part of company’s filings submitted to BSE.
